Going Public in Canada: Advantages and Advice for U.S. Cannabis Companies Guest post by Cam Mingay, senior partner in the Securities Group and Rowan Groenewald, associate in the Business...

After initially filing its preliminary prospectus in April, ACMPR licensed producer MedReleaf (TSX: LEAF) has filed the final prospectus for its $100.7mm initial public offering and secondary offering, selling shares...

Cannabis RTOs/IPOs Guest post by Steven Looi and Michael Miller of Initiative Capital  On March 11th, 2016, Ontario based Supreme Pharmaceuticals Inc. (CSE: SL) issued a press release to indicate...